EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.4.21.91 | Hepatitis C |
11009354 |
1-Aminocyclopropaneboronic acid: synthesis and incorporation into an inhibitor of hepatitis C virus NS3 protease. |
ongoing research therapeutic application unassigned |
2 2 0 |
3.4.21.91 | Dengue |
28752033 |
3,5-Bis(arylidene)-4-piperidones as potential dengue protease inhibitors. |
causal interaction therapeutic application unassigned |
3 4 0 |
3.4.21.91 | Dengue |
28758854 |
3D-QSAR pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation toward identifying lead compounds for NS2B-NS3 protease inhibitors. |
causal interaction therapeutic application unassigned |
4 1 0 |
3.4.21.91 | Hepatitis C |
8609472 |
A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 protease. |
unassigned |
0 |
3.4.21.91 | Infections |
25746332 |
A dark-to-bright reporter cell for classical swine fever virus infection. |
unassigned |
0 |
3.4.21.91 | Hepatitis C |
11844705 |
A designed P1 cysteine mimetic for covalent and non-covalent inhibitors of HCV NS3 protease. |
therapeutic application unassigned |
3 0 |
3.4.21.91 | Dengue |
19682971 |
A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease. |
causal interaction therapeutic application unassigned |
1 2 0 |
3.4.21.91 | Infections |
31919100 |
A fluorescence-activatable reporter of flavivirus NS2B-NS3 protease activity enables live imaging of infection in single cells and viral plaques. |
diagnostic usage unassigned |
3 0 |
3.4.21.91 | Hepatitis C |
10403679 |
A high throughput assay of the hepatitis C virus nonstructural protein 3 serine proteinase. |
diagnostic usage unassigned |
3 0 |
3.4.21.91 | Hepatitis C |
9888975 |
A high-throughput radiometric assay for hepatitis C virus NS3 protease. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 1 1 4 |